Starpharma Pty Ltd.
🏢 View company profile →21Patents
19Active
21Granted
51Portfolio score
Filing activity: Mar 28, 2002 → Aug 30, 2021 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572459B2 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8586705B2 | Macromolecular compounds having controlled stoichiometry | Human Necessities | 6 | Active |
| US10265409B2 | Macromolecules | Chemistry; Metallurgy | 3 | Active |
| US9744246B2 | Macromolecules | Chemistry; Metallurgy | 3 | Active |
| US8703116B2 | Modified macromolecule | Chemistry; Metallurgy | 2 | Active |
| US9585387B1 | PEHAM dendrimers for use in agriculture | Chemistry; Metallurgy | 2 | Active |
| US11118016B2 | Therapeutic dendrimer | Human Necessities | 2 | Active |
| US8337823B2 | Modified macromolecule | Chemistry; Metallurgy | 2 | Active |
| US7589056B2 | Agent for the prevention and treatment of sexually transmitted diseases-I | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8420067B2 | Targeted polylysine dendrimer therapeutic agent | Human Necessities | 1 | Active |
| US8258259B2 | Macromolecular compounds having controlled stoichiometry | Human Necessities | 1 | Active |
| US9127130B2 | Polylysine dendrimer contrast agent | Chemistry; Metallurgy | 1 | Active |
| US10149885B2 | Method of treatment or prophylaxis of infections of the eye | Human Necessities | 0 | Active |
| US11970583B2 | Therapeutic dendrimer | Human Necessities | 0 | Active |
| US8193248B2 | Contraceptive composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US11219691B2 | Method of treatment or prophylaxis of infections of the eye | Human Necessities | 0 | Active |
| US9155760B2 | Method of prophylaxis of bacterial vaginosis | Emerging Cross-Sectional Technologies | 0 | Active |
| US8158575B2 | Agent for the prevention and treatment of sexually transmitted diseases-I | Emerging Cross-Sectional Technologies | 0 | Active |
| US12071517B2 | Therapeutic dendrimer | Chemistry; Metallurgy | 0 | Active |
| US10730999B2 | Dendrimer-drug conjugates | Chemistry; Metallurgy | 0 | Active |
| US8568753B2 | Delivery system | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.